Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Haddon

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Thrombosis Research|July 15, 1986
Pasteurisation induced changes in an antithrombin III concentrateL Winkelman, M E Haddon
Thrombosis and Haemostasis|April 8, 1988
Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiencyH M Daly, M E Haddon
Thrombosis and Haemostasis|September 1, 1996
Simplified procedure for thromboplastin calibrationK W Denson, S V Reed, M E Haddon
Thrombosis and Haemostasis|September 1, 1995
The modified APC resistance testK W Denson, S V Reed, M E Haddon
Thrombosis and Haemostasis|January 1, 1995
Validity of the INR system for patients with liver impairmentK W Denson, S V Reed, M E Haddon
Thrombosis Research|June 1, 1994
An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre studyS V Reed, M E Haddon, K W Denson
Vox Sanguinis|January 1, 1985
A pasteurized antithrombin III concentrate for clinical useJ K Smith, L Winkelman, D R Evans, et al.
Transfusion|September 1, 1978
Methods of assessing factor VIII content of stored fresh frozen plasma intended for preparation of factor VIII concentratesJ K Smith, T J Snape, M E Haddon, et al.
Thrombosis Research|January 1, 1996
A more discriminating test for APC resistance and a possible screening test to include protein C and protein SK W Denson, M E Haddon, S V Reed, et al.
Thrombosis and Haemostasis|June 30, 1986
A pasteurised concentrate of human plasma factor XIII for therapeutic useL Winkelman, G E Sims, M E Haddon, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Thrombosis Research|July 15, 1986
Pasteurisation induced changes in an antithrombin III concentrateL Winkelman, M E Haddon
Thrombosis and Haemostasis|April 8, 1988
Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiencyH M Daly, M E Haddon
Thrombosis and Haemostasis|September 1, 1996
Simplified procedure for thromboplastin calibrationK W Denson, S V Reed, M E Haddon
Thrombosis and Haemostasis|September 1, 1995
The modified APC resistance testK W Denson, S V Reed, M E Haddon
Thrombosis and Haemostasis|January 1, 1995
Validity of the INR system for patients with liver impairmentK W Denson, S V Reed, M E Haddon
Thrombosis Research|June 1, 1994
An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre studyS V Reed, M E Haddon, K W Denson
Vox Sanguinis|January 1, 1985
A pasteurized antithrombin III concentrate for clinical useJ K Smith, L Winkelman, D R Evans, et al.
Transfusion|September 1, 1978
Methods of assessing factor VIII content of stored fresh frozen plasma intended for preparation of factor VIII concentratesJ K Smith, T J Snape, M E Haddon, et al.
Thrombosis Research|January 1, 1996
A more discriminating test for APC resistance and a possible screening test to include protein C and protein SK W Denson, M E Haddon, S V Reed, et al.
Thrombosis and Haemostasis|June 30, 1986
A pasteurised concentrate of human plasma factor XIII for therapeutic useL Winkelman, G E Sims, M E Haddon, et al.
Pageof 2